➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Mallinckrodt
Dow
Johnson and Johnson
McKesson

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: etretinate


Email this page to a colleague

« Back to Dashboard

ETRETINATE

CASRN: 54350-48-0

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
McKesson